Gene · 3535
Papers1,872
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,872
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology. | Virchows Arch | 2024 | 37530792 | PubTator, text mining | PubMed |
| PVT1 interacts with polycomb repressive complex 2 to suppress genomic regions with pro-apoptotic and tumour suppressor functions in multiple myeloma. | Haematologica | 2024 | 37496441 | PubTator, text mining | PubMed |
| IGL CDR3 Hydropathy and Antigen Chemical Complementarity Associated with Greater Disease-Free Survival in Lung Adenocarcinoma: Implications for Gender Disparities. | Biochem Genet | 2024 | 37392243 | PubTator, text mining | PubMed |
| Rational use of eculizumab in secondary atypical hemolytic uremic syndrome. | Front Immunol | 2023 | 38274833 | PubTator, text mining | PubMed |
| Circadian light therapy and light dose for depressed young people: a systematic review and meta-analysis. | Front Public Health | 2023 | 38259764 | PubTator, text mining | PubMed |
| Human VH4-34 antibodies derived from B1 cells are more frequently autoreactive than VH4-34 antibodies derived from memory cells. | Front Immunol | 2023 | 38162664 | PubTator, text mining | PubMed |
| Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis. | Blood Cancer J | 2023 | 38114462 | PubTator, text mining | PubMed |
| Atypical B cells consist of subsets with distinct functional profiles. | iScience | 2023 | 38098745 | PubTator, text mining | PubMed |
| Systems immunology spanning tumors, lymph nodes, and periphery. | Cell Rep Methods | 2023 | 38086385 | PubTator, text mining | PubMed |
| Identification of TRDV-TRAJ V domains in human and mouse T-cell receptor repertoires. | Front Immunol | 2023 | 38077312 | PubTator, text mining | PubMed |
| Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia. | Mol Ther Oncolytics | 2023 | 38075241 | PubTator, text mining | PubMed |
| Cytogenetic Profile in Monoclonal Gammopathy of Undetermined Significance, Smoldering and Symptomatic Multiple Myeloma: A Study of 1087 Patients with Highly Purified Plasma Cells. | Cancers (Basel) | 2023 | 38067393 | PubTator, text mining | PubMed |
| The effectiveness of blinatumomab in clearing measurable residual disease in pediatric B-cell acute lymphoblastic leukemia patients detected by next-generation sequencing. | Cancer Med | 2023 | 38063317 | PubTator, text mining | PubMed |
| An Ancestral Major Histocompatibility Complex Organization in Cartilaginous Fish: Reconstructing MHC Origin and Evolution. | Mol Biol Evol | 2023 | 38059517 | PubTator, text mining | PubMed |
| A lung-selective delivery of mRNA encoding broadly neutralizing antibody against SARS-CoV-2 infection. | Nat Commun | 2023 | 38052844 | PubTator, text mining | PubMed |
| Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression. | Nat Genet | 2023 | 38049665 | PubTator, text mining | PubMed |
| [Angioimmunoblastic T-cell lymphoma with monoclonal B cell and plasma cell hyperplasia]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38049326 | PubTator, text mining | PubMed |
| Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates. | Nat Commun | 2023 | 38042809 | PubTator, text mining | PubMed |
| Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors. | J Immunother Cancer | 2023 | 38030303 | PubTator, text mining | PubMed |
| Diagnostic Values of METTL1-Related Genes and Immune Characteristics in Systemic Lupus Erythematosus. | J Inflamm Res | 2023 | 38026241 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3535/papers?page=5